Notice of Correction to Award Budget information for NHGRI Sequencing Funding Opportunity Announcement RFA-HG-10-015


Notice Number:  NOT-HG-11-012

Key Dates

Release Date:   January 28, 2011

Related Notices

RFA-HG-10-015

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to modify the information in the FOA regarding permitted cost caps for applications to RFA-HG-10-015, Genome Sequencing and Analysis Centers (U54).

This FOA states a direct cost cap of $45M per year. With this Notice, NHGRI changes the award cap to $65M per year total costs.  Changing the emphasis to total costs, rather than direct costs, is to encourage flexibility in how the applicant proposes to organize the activity to reduce costs.

The changes occur to Section II, Award Information:

Original language:

Award Budget Information:  Individual application budgets should not exceed $45M per year, direct costs and must reflect actual needs of proposed project.

Revised language:

Award Budget Information:  Individual application budgets should not exceed $65M per year, total costs. All direct costs must reflect the actual needs of the proposed project.

Inquiries

Please direct all inquiries about this Notice to:

Adam Felsenfeld, Ph.D.
Program Director
National Human Genome Research Institute
National Institutes of Health
5635 Fishers Lane, Suite 4105 MSC 9305
Bethesda, MD 20892 (mail)
Telephone: 301 496-7531
Email: adam_felsenfeld@mail.nih.gov
www.genome.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.